All stock reports

KRITI evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-21T13:14:49.322513+00:00

Metrics

latest_annual_period
2026-03-31
revenue
5873673000.0
net_income
11297000.0
operating_cash_flow
79840000.0
free_cash_flow
-263168000.0
total_assets
4832534000.0
total_liabilities
2610056000.0
total_equity
2222478000.0
cash
155371000.0
total_debt
911153000.0
revenue_growth
-0.18636696781814943
earnings_growth
-1.2642696734350145
net_margin
0.0019233280436278968
roe
0.005083064939225495
debt_to_equity
0.4099716622616737
cash_conversion
7.067363016730106
free_cash_flow_margin
-0.04480467332791594
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-82503a5db5c18f58def4fee641bf64ed11231c7b8b857718e6587c41efa0ac17
Policy
stock-decisions-v1
Evidence bundle hash
d2648eb8cf31989a68177f3eeda0960b72879ddd5624347e9fcbba5b30aa0e56
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 79eaaa614d305f6bd5affe14c3ee4d254eac12a05d0de32e33a859d63d6cdfc4
  • daily-price: c4472b12234d5d17f65b2a672cb9ed91b7cf95074f59243f1a2e751fd155de7c
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits